Delisting riskPopularity #3,845
Standard BioTools (LAB)
Sells retained mass-cytometry and microfluidic genomics systems after the SomaScan sale.
$0.7498
After hours+0.00 (+0.04%)
At close$0.7495(+1.02%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
−$0.02
Revenue estimate
$18.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.05−$0.04−$0.04−$0.09$0.06−$0.02−$0.07Pending
Estimate−$0.07−$0.04−$0.04−$0.04−$0.03−$0.02−$0.01−$0.02
Surprise+28.6%0.0%0.0%−107.7%+300.0%0.0%−449.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$46.7M$40.8M$21.8M$19.6M$23.8M$21.1M$20.1MPending
Estimate$43.0M$40.1M$39.8M$18.0M$18.5M$17.8M$20.8M$18.8M
Surprise+8.6%+1.7%−45.4%+8.6%+28.6%+18.8%−3.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.01 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | −$0.03 | — | — |
| Sep 2027 | −$0.04 | — | — |
| Jun 2027 | −$0.04 | — | — |
| Mar 2027 | −$0.06 | — | — |
| Dec 2026 | −$0.02 | — | — |
| Nov 2026 | −$0.02 | — | — |
| Aug 2026 | −$0.01 | −$0.07 | −449.0% |
| May 2026 | −$0.02 | −$0.02 | 0.0% |
| Feb 2026 | −$0.03 | $0.06 | +300.0% |
| Nov 2025 | −$0.04 | −$0.09 | −107.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.01 | — | — | $25.6M | — | — | — |
| Sep 2028 | $0.00 | — | — | $19.8M | — | — | — |
| Jun 2028 | $0.00 | — | — | $21.9M | — | — | — |
| Mar 2028 | $0.00 | — | — | $23.0M | — | — | — |
| Dec 2027 | −$0.03 | — | — | $20.9M | — | — | — |
| Sep 2027 | −$0.04 | — | — | $18.7M | — | — | — |
| Jun 2027 | −$0.04 | — | — | $21.3M | — | — | — |
| Mar 2027 | −$0.06 | — | — | $21.2M | — | — | — |
| Dec 2026 | −$0.02 | — | — | $21.0M | — | — | — |
| Nov 3, 2026 | −$0.02 | — | — | $18.8M | — | — | — |
| Aug 5, 2026 | −$0.01 | −$0.07 | −449.0% | $20.8M | $20.1M | −3.4% | +2.0% |
| May 5, 2026 | −$0.02 | −$0.02 | 0.0% | $17.8M | $21.1M | +18.8% | −1.1% |
| Feb 24, 2026 | −$0.03 | $0.06 | +300.0% | $18.5M | $23.8M | +28.6% | +1.7% |
| Nov 4, 2025 | −$0.04 | −$0.09 | −107.7% | $18.0M | $19.6M | +8.6% | −4.0% |
| Aug 11, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 14, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 17, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 6, 2021 | |||||||
| May 7, 2021 | |||||||
| Feb 10, 2021 | |||||||
| Nov 6, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 11, 2020 | |||||||
| Feb 10, 2020 | |||||||
| Nov 7, 2019 | |||||||
| Aug 1, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Nov 1, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 3, 2018 | |||||||
| Feb 8, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 3, 2017 | |||||||
| May 4, 2017 | |||||||
| Feb 8, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 4, 2016 | |||||||
| Oct 29, 2015 | |||||||
| Aug 8, 2015 |